Given the impaired spheroid generation upon combination treatment, we examined the canonical NSCLC stemness markers (e.g., SOX2, CD44, CD133, EpCAM) after irradiation with or without cabozantinib. The gene discussed is EPCAM; the disease is non-small cell lung carcinoma.